SNDX
Syndax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.56
−0.58%Leverage
- Debt / equity
- 39.03x
- Net debt / equity
- 16.75x
- Debt / assets
- 0.84x
- Debt / EBITDA
- -4.36x
- Net debt / EBITDA
- -1.87x
Liquidity & coverage
- Current ratio
- 6.77x
- Quick ratio
- 6.44x
- Cash ratio
- 5.50x
- Interest coverage
- -2.27x
- EBITDA / interest
- -1.58x
- Working capital
- $575.4M
Cash & dividend
- FCF / debt
- -0.37x
- Cash flow / debt
- -0.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026